Chad Winters
Vermogen: 518 941 $ op 31-07-2026
Vermogen: 518 941 $ op 31-07-2026
Chad R.
Winters is currently Chief Accounting Officer & VP-Finance at West Pharmaceutical Services, Inc. since 2024.
Former positions include Director at La Causa, Inc. and Controller, Senior VP-Finance & Accounting at Amneal Intermediate, Inc. Education includes an undergraduate degree from Villanova University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 1.522 ( 0% ) | 518 941 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Comptroller/Controller/Auditor | 01-10-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Comptroller/Controller/Auditor | - |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Health Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau